Kiran K Telukunta is an accomplished professional with extensive experience in computing systems, cloud architecture, and bioinformatics. Currently serving as a Computing Systems Development worker at IOCB Prague since November 2022, Kiran focuses on the maintenance and development of HPC Cluster infrastructure. Kiran has held various roles, including Informations Systems Assistant at the International Solar Energy Society since August 2011, and has a strong background as a Cloud Architect at mondas GmbH, where responsibilities included planning and implementing institutional cloud solutions. Kiran's expertise extends to scientific research support, having coordinated cloud environments for bioinformatics at VIB and contributed as an Honorary Consultant at CSIR-NEIST. With a Doctor of Philosophy in Pharmaceutical Bioinformatics from Albert-Ludwigs-Universität Freiburg, Kiran possesses a robust educational foundation in artificial intelligence and bioinformatics, coupled with hands-on experience in scientific IT infrastructure and software development across multiple research institutions and companies.
This person is not in the org chart
This person is not in any teams
IOCB Prague - Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
1 followers
The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) is a leading scientific institution in the Czech Republic, recognized internationally. Its primary mission is basic research in the fields of chemical biology and medicinal chemistry, organic and material oriented chemistry, chemistry of natural compounds, biochemistry and molecular biology, physical chemistry, theoretical chemistry, and analytical chemistry. Today, over 600 employees including 180 students in 45 research and service groups are involved in a broad spectra of disciplines, which results in more than 250 publications per year, including papers in the most cited prestigious journals such as Nature or Science. The Institute’s emphasis on interaction between chemistry and other sciences leads frequently to medicinal applications. An integral part of the mission of the Institute is, therefore, to transfer the scientific results into assets which help people to live better lives. Together with the research expertise, a system of technology transfer, IP management and commercialization have intensively been built-up. Through its subsidiary company IOCB TTO, the Institute helps scientists to transform ideas into patents and matches their research results with interests of commercial partners to bring novel ideas to human use or technology market.